R

Carillon Awarded DARPA Contract for Next Generation Satellite-to-Satellite Free Space Optical Communication (FSOC)

Thursday, September 23, 2021 - 7:00am

The Defense Advanced Research Projects Agency (DARPA) has awarded Carillon Technologies a $6.4M contract to prototype next generation satellite-to-satellite communication systems derived from cutting edge commercial Holographic Optical Beam Steering (HOBS) technology.

Key Points: 
  • The Defense Advanced Research Projects Agency (DARPA) has awarded Carillon Technologies a $6.4M contract to prototype next generation satellite-to-satellite communication systems derived from cutting edge commercial Holographic Optical Beam Steering (HOBS) technology.
  • Lightweight and affordable satellite-to-satellite optical communication is a breakthrough technology, not only for commercial and defense communication constellations currently being deployed, but also for new high-performance, highly-survivable space architectures, said Dr. John D. Evans, CEO of Carillon Technologies.
  • This new solid-state HOBS technology will provide a step change in size, weight, and cost for satellite Free Space Optical Communications (FSOC) systems.
  • Dr. Geb Akselrod, CTO of Lumotive notes, Were excited to collaborate with Carillon and DARPA.

Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology

Wednesday, September 22, 2021 - 9:05pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210922005141/en/
    ICON receives multi-million Euro R&D support to accelerate decentralized clinical trial technology and data solutions.
  • As the most advanced healthcare intelligence and clinical research organisation in the industry, ICON will utilise the funding to further invest in the build-out of its world-class technology and data solutions architecture.
  • The support will promote broad clinical research participation while also delivering real-time access to data, higher levels of security, and improved timelines and reduced costs for customers.
  • The R&D support will help development of tech-enabled systems that provide greater flexibility and reduce the burden felt by clinical trial participants.

The 2021 DPHARM Idol Companies Disrupting Clinical Trials Announced from the Conference Forum

Wednesday, September 22, 2021 - 6:00pm

NEW YORK, Sept. 22, 2021 /PRNewswire-PRWeb/ -- The Conference Forum to announce the 2021 presenting companies presenting at the annual DPHARM Idol Disrupt, happening September 28, 2021, virtually, at the DPHARM: Disruptive Innovations to Advance Clinical Trials conference.

Key Points: 
  • NEW YORK, Sept. 22, 2021 /PRNewswire-PRWeb/ -- The Conference Forum to announce the 2021 presenting companies presenting at the annual DPHARM Idol Disrupt, happening September 28, 2021, virtually, at the DPHARM: Disruptive Innovations to Advance Clinical Trials conference.
  • DPHARM Idol Disrupt is an annual live show taking place at the DPHARM conference.
  • Pro-ficiency, who reduces the costs and complications of clinical training by using comprehensive analytics that enrich and protect clinical research.
  • DPHARM Idol Disrupt 2021 will kick off with an update from the 2020 Winner, King-Devick Technologies, who wowed judges last year with their objective oculomotor disorder assessment tool.

EQS-News: Media Release: Sensirion Inside - Atmocube by ATMO(R)

Wednesday, September 22, 2021 - 6:57pm

Atmocube helps building owners implement their indoor air quality strategies to comply with healthy and green building standards more effectively.

Key Points: 
  • Atmocube helps building owners implement their indoor air quality strategies to comply with healthy and green building standards more effectively.
  • "We've been using Sensirion sensors in multiple products, primarily due to their accuracy, overtime stability and small footprint.
  • Learn more about Atmocube at: https://atmotube.com/pages/atmocube
    More about Sensirion environmental sensors can be found at: www.sensirion.com
    Headquartered in Stfa, Switzerland, Sensirion AG is a leading manufacturer of digital microsensors and systems.
  • Sensirion sensors are commonly used in the medical, industrial and automotive sectors, and in analytical instruments, consumer goods and HVAC products.

Mammoth Freighters Adds Widebody MRO Facility to B777 Cargo Conversion Program Initiative

Wednesday, September 22, 2021 - 6:16pm

ORLANDO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mammoth Freighters LLC (Mammoth) announced today a strategic investment in a world class widebody maintenance and modification facility to support its Boeing 777-200LR and 777-300ER passenger-to-freighter conversion programs.

Key Points: 
  • ORLANDO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mammoth Freighters LLC (Mammoth) announced today a strategic investment in a world class widebody maintenance and modification facility to support its Boeing 777-200LR and 777-300ER passenger-to-freighter conversion programs.
  • Through its investment, Mammoth is embarking on a long-term partnership with GDC Technics (GDC), a global aerospace company with extensive expertise in Engineering & Technical services, Modifications, Electronic Systems, R&D, and MRO services.
  • Located at Alliance Airport in Fort Worth, Texas, GDC has a state-of-the-art facility with 840,000 sq feet and six widebody hangar bays for modification and maintenance work on 777 aircraft.
  • Brad Foreman, GDC CEO, added, We believe Mammoth is positioned to be the leading passenger-to-freighter conversion company in the world and are excited about the potential.

Transgene’s Two Innovative Platforms Progressing Well - Financial Visibility Extended Until End 2023

Wednesday, September 22, 2021 - 4:45pm

In the first half of 2021, the income recognized under this collaboration agreement was 1.3 million (2.2 million in the first half of 2020).

Key Points: 
  • In the first half of 2021, the income recognized under this collaboration agreement was 1.3 million (2.2 million in the first half of 2020).
  • The research tax credit amounted to 3.5 million for the first half of 2021, compared to 2.9 million for the first half of 2020.
  • General and administrative expenses amounted to 3.1 million for the first half of 2021 compared to 3.3 million for the same period in 2020.
  • With Transgenes myvac platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual.

$2+ Billion Early Toxicity Testing Markets - Global Opportunity Analysis and Industry Forecast, 2021-2030 - ResearchAndMarkets.com

Wednesday, September 22, 2021 - 2:13pm

The Global Early Toxicity Testing Market size was valued at USD 816.0 million in 2020 and is predicted to reach USD 2012.8 million by 2030 with a CAGR of 9.75% from 2021-2030.

Key Points: 
  • The Global Early Toxicity Testing Market size was valued at USD 816.0 million in 2020 and is predicted to reach USD 2012.8 million by 2030 with a CAGR of 9.75% from 2021-2030.
  • Geographically, North America is expected to hold the major market share owing to the increased adoption of early toxicity testing.
  • Also, technological advancements and presence of developed infrastructure along with aggressive R&D activities are expected to promote the growth of early toxicity testing market.
  • The global early toxicity testing market is highly competitive and consists of numerous market players.

Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries

Wednesday, September 22, 2021 - 2:30pm

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.

Key Points: 
  • Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.
  • The project will strengthen access to equitable health services, build community resilience to climate shocks and help women forge their own path to a healthier future.
  • Each project addresses strengthening health systems in unique ways and aligns with countries national health needs.
  • In this release, Takeda is sometimes used for convenience where references are made to Takeda and its subsidiaries in general.

IV BioHoldings Debuts Liquid Biopsy Portfolio; Partners with P4 Diagnostix to Scale Commercialization of Non-Invasive Lung, Liver and Breast Diagnostics

Wednesday, September 22, 2021 - 4:14pm

Collectively, the IVBH companies comprise eight clinical-ready diagnostics, spanning the care continuum for lung cancer, non-alcoholic fatty liver disease (NAFLD) and breast cancer, respectively.

Key Points: 
  • Collectively, the IVBH companies comprise eight clinical-ready diagnostics, spanning the care continuum for lung cancer, non-alcoholic fatty liver disease (NAFLD) and breast cancer, respectively.
  • IVBH is now scaling to support its flagship lung, liver and breast programs through clinical development and commercialization.
  • We are a bio innovation studio specializing in de novo company creation at the intersection of diagnostics and life sciences.
  • P4 is made up of these industry-leading companies: Theranostix, Long Island Pathology, Platinum Pathology, Metamark Laboratories and P4 Clinical.

Increasing Sales of Passenger Vehicles Position North America as a Highly Lucrative Market for Car Security Systems: Future Market Insights

Wednesday, September 22, 2021 - 2:30pm

Demand for car security system is expected to rise by year on year (YoY) growth of 5.4% in 2021, owing to the increasing production of passenger cars and luxury vehicles.

Key Points: 
  • Demand for car security system is expected to rise by year on year (YoY) growth of 5.4% in 2021, owing to the increasing production of passenger cars and luxury vehicles.
  • These vehicles come inbuilt with these security systems, thus, rise in production of these vehicles will drive the market growth.
  • Increasing incidence of vehicle theft is a primary factor accelerating the sales of car security system.
  • Government initiatives adopted for making car security systems like GPS and vehicle trackers mandatory in every car is boosting the growth of the market.